Pricing Log in Create free account

OnKure Therapeutics, Inc. (OKUR) vs Unicycive Therapeutics, Inc. (UNCY)

OnKure Therapeutics, Inc. and Unicycive Therapeutics, Inc. are both Biotechnology companies. OnKure Therapeutics, Inc. and Unicycive Therapeutics, Inc. are of similar size ($102.3M and $96.9M). Across the 8 metrics below, OnKure Therapeutics, Inc. leads on 6 and Unicycive Therapeutics, Inc. on 2.

Valuation

Metric OKUR UNCY Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 0.73 1.76 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.82 n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (138.34%) (46.33%) (34.89%)
Free cash flow yield (37.94%) (29.73%) (24.52%)

Profitability

Metric OKUR UNCY Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (46.91%) (101.07%) (50.12%)
Return on assets (44.24%) (69.05%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OKUR UNCY Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 71.20% 70.18% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OKUR UNCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 26.75 3.81 4.89
Net debt to EBITDA 0.95 1.43 1.01

Dividend

Metric OKUR UNCY Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric OKUR UNCY Biotechnology median
Market cap 102.26m 96.94m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack